Technology Overview
ADAPTIR™ and ADAPTIR-FLEX™ are proprietary platform technologies that produce novel drug candidates with the potential to improve outcomes for cancer patients.
The combination of our proprietary platform together with our institutional expertise in modulating levers of binding domains, affinity, valency and positioning allows for a differentiated pipeline of tumor-targeted immuno-oncology assets.
